Lexeo Therapeutics, Inc. Common Stock
Status: Publicly traded
Direct answer
Lexeo Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker LXEO.
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic...
Can you invest in Lexeo Therapeutics, Inc. Common Stock?
Yes. Lexeo Therapeutics, Inc. Common Stock trades publicly on NASDAQ as LXEO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lexeo Therapeutics, Inc. Common Stock
Detailed equity research is provided by MarketSnap.